A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.Gerald Steven Falchook,Manish R. Patel,Timothy A. Yap,Kristen McEachern,Kristy Kuplast-Barr,Luke Utley,Lisa Cleary,Erika Manyak,Viviana Bozon,Sudha Parasuraman,Melissa Lynne JohnsonJOURNAL OF CLINICAL ONCOLOGY(2021)引用 8|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要